Portefeuille

Des entreprises à forte croissance, à différents stades de développement (Capital Innovation et Capital Développement).

Proclara Biosciences

222, Third St
MA 02142 Cambridge - ETATS UNIS

Date de création : 2008

Nombre d'employés : 19

Proclara is pioneering a new approach to treating neurodegenerative diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by Alzheimer’s, Parkinson’s, and other diseases caused by protein misfolding. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.

222, Third St
MA 02142 Cambridge - ETATS UNIS http://www.proclarabio.com/

Dirigeant

Franz HEFTI